(IDXX) IDEXX Laboratories - Ratings and Ratios

IDEXX Laboratories Inc (NASDAQ:IDXX) is a global leader in veterinary diagnostics and water quality testing. With a strong foothold in the animal health and diagnostics space, IDEXX serves a diverse range of markets, including companion animals, livestock, poultry, dairy, and water testing. Their products and services are distributed across Africa, the Asia Pacific, Canada, Europe, Latin America, and the United States.

The company operates through three core segments: Companion Animal Group, Water Quality Products, and Livestock, Poultry and Dairy. IDEXX is known for its innovative diagnostic solutions, including point-of-care instruments, rapid assay test kits, and reference laboratory services. Their offerings also extend to practice management systems, diagnostic imaging, and biological materials testing for the biomedical research community.

IDEXX’s product portfolio includes SNAP rapid assays, in-clinic analyzers for chemistry, hematology, and immunoassay testing, as well as water testing solutions like Colilert and Quanti-Tray. In addition to their veterinary focus, the company provides human medical point-of-care products and laboratory diagnostics services.

With a market capitalization of $37.7 billion and a P/E ratio of 43.12, IDEXX is valued for its strong growth prospects and leadership in the healthcare equipment sector. The company’s financials reflect a P/B ratio of 24.05 and a P/S ratio of 9.81, indicating a premium valuation driven by its dominant market position and high-margin recurring revenue streams.

IDEXX distributes its products through a combination of direct sales, customer service, technical support, and independent distributors. Headquartered in Westbrook, Maine, the company has built a reputation for innovation and reliability since its founding in 1983. For more information, visit their website at https://www.idexx.com.